NEW YORK (GenomeWeb News) – The United Kingdom's National Institute of Health Research will work with GeneGo in a collaboration that the company hopes will lead to development of a pathway analysis tool for the central nervous system.

GeneGo said it is working with NIHR's Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and King's College London through its MetaMiner CNS Partnership Program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.